Brief: Corline Biomedical Q2 Pre-Tax Loss At SEK 2.6 Mln
Aug 27 (Reuters) - Corline Biomedical AB CLBIO.ST :
* Q2 NET SALES SEK 0.6 MILLION VERSUS SEK 0.4 MILLION YEAR
AGO
* Q2 PRE-TAX LOSS SEK 2.6 MILLION VERSUS LOSS SEK 2.5
MILLION
YEAR AGO
Source text for Eikon: ID:nGNEc74dX
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln